EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Agasta Software is engaged in research, development and commercialization of medical devices
According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million
Subscribe To Our Newsletter & Stay Updated